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ABSTRACT
Aim: Long-chain polyunsaturated fatty acids (LCPUFAs) are immunomodulatory, but their
role in allergy development is controversial. We investigated whether proportions of
LCPUFAs in serum phospholipids were related to allergic diagnosis, seafood intake and
LCPUFA proportions in cord blood.
Methods: Serum was obtained from 148 birth cohort children at 13 years of age. Forty had
atopic eczema, 53 had respiratory allergy, and 55 were nonallergic. Proportions of LCPUFAs
were determined in serum phospholipids; cord blood from 128 of the individuals was
previously analysed. Seafood intake was estimated using questionnaires.
Results: Allergic and nonallergic individuals did not differ significantly regarding individual
LCPUFAs. However, arachidonic acid over docosahexaenoic acid (DHA) ratio was higher in
allergic, compared with nonallergic, adolescents. In nonallergic individuals, LCPUFA
proportions in cord serum and adolescent serum correlated weakly. In individuals with
atopic eczema and respiratory allergy, these correlations were weak or absent. A moderate
correlation between seafood intake and serum DHA was seen in nonallergic individuals
and those with respiratory allergy, but not in those with atopic eczema.
Conclusion: Serum LCPUFA pattern was similar in allergic and nonallergic adolescents.
Fatty acid metabolism may be altered in atopic eczema subjects, suggested by poor
correlations between fatty acid intake and serum levels.
INTRODUCTION
Polyunsaturated fatty acids (PUFAs) are found in phospho-
lipid membranes, including those surrounding serum lipo-
proteins, thrombocytes and cells. PUFAs are grouped into
the n-3 and n-6 series, depending on the position of the
double bonds. Some long-chain polyunsaturated fatty acids
(LCPUFAs) are intracellular messengers and substrates for
the production of mediators, such as prostaglandins and
thromboxanes (1). Both n-3 and n-6 LCPUFAs strongly
oppose activation of T cells, in particular those of the Th1
type (2–4). We recently found that high proportions of
LCPUFAs in the cord serum of newborn infants were
positively associated with the development of sensitisation
and respiratory allergy during childhood (5). Our interpre-
tation was that LCPUFAs hampered immune activation in
response to neonatal microbial colonisation, thereby pre-
venting immune maturation and natural tolerance devel-
opment.
The serum fatty acid pattern in a foetus reflects what has
been transferred through the placenta from the maternal
circulation during pregnancy (6). In children and adults,
serum LCPUFAs derive mainly from the diet, but also from
endogenous production from essential precursors of the
omega-6 and omega-3 series, that is, 18:2 n-6 (linoleic acid,
LA) and 18:3 n-3 (alpha-linolenic acid, ALA), respectively.
These essential PUFAs are mainly found in vegetable oils.
LCPUFAs of the n-3 series are mainly found in fish and
other seafood, while n-6 LCPUFAs are found in both fish
and meat. LCPUFAs are incorporated into membranes,
used as an energy source and act as substrates for the
production of a range of bioactive compounds (7). For
example, arachidonic acid is the precursor of prostaglan-
Key notes
 Long-chain polyunsaturated fatty acids (LCPUFAs) have
immunomodulatory effects, but their role in allergy
development is controversial.
 The LCPUFA pattern in serum at 13 years of age was
related to LCPUFA proportions at birth and present
seafood intake in nonallergic individuals, but the
correlations were weaker or nonexistent in subjects
with respiratory allergy or atopic eczema.
 Our results suggest that fatty acid metabolism is
modified in individuals with atopic eczema.
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dins, leukotrienes and thromboxanes (1). Consequently,
bodily consumption of LCPUFAs may be elevated in
inflammatory processes, including allergic inflammation
during which prostaglandins and leukotrienes are produced
from mast cells and macrophages in response to allergen
exposure. This phenomenon was demonstrated in an
experimental respiratory allergy model in mice, in which a
rapid decrease in serum levels of both n-3 and n-6
LCPUFAs accompanied the inflammatory reaction trig-
gered by the allergen challenge (8). We previously reported
that women with respiratory allergy and atopic eczema had
lower proportions of n-3 LCPUFAs in breastmilk than
nonallergic women, despite having at least the same high
fish intake, which could suggest greater consumption of
LCPUFAs in allergic than healthy individuals (9).
The present study examined serum phospholipid
LCPUFA patterns in 13-year-old adolescents with either
respiratory allergy, atopic eczema or without any allergic
symptoms. The individuals had previously been character-
ised with respect to LCPUFA patterns in cord blood
obtained at parturition (5). We could thereby relate the
LCPUFA pattern at 13 years of age to the pattern in the
cord blood and examine whether allergic and nonallergic
individuals differed when it came to changes in LCPUFA
patterns over time. By assessing seafood intake using a food
frequency questionnaire, we could examine the relation
between seafood intake and serum n-3 LCPUFA levels in
allergic and nonallergic individuals.
METHODS
A total of 148 subjects aged 13 years were selected from a
birth cohort consisting of all 1228 children born during a
one-year period from February 1996 to January 1997 at the
€Ostersund Hospital in J€amtland, Sweden. Pregnant women
were recruited in gestational week 18, and the children
were followed from birth until 13 years of age, with regular
assessments of allergic sensitisation by skin prick tests at the
ages of one and four and allergic symptoms by question-
naires at the ages of one four and seven, as previously
described (5,10). At 13 years of age, 794 adolescents filled
out a new questionnaire regarding allergic symptoms and
were skin prick tested for milk, eggs, fish, wheat, soy, cat,
dog, horse, timothy grass and birch using standardised
extracts (ALK, H€orsholm, Denmark; 10 histamine equiva-
lent prick units potency). A single nurse conducted all the
skin prick tests, and reproducibility was repeatedly checked
according to international recommendations (11).
Of the 794 adolescents who filled out the questionnaire
and received a skin prick test, 130 had respiratory allergy,
but no atopic manifestations from other organs, and at least
one positive reaction in the skin prick test. Respiratory
allergy was defined as fulfilling one or more of the following
criteria: wheeze in the past year, doctor’s diagnosis of
asthma, treatment with an asthma inhaler or a positive
answer to the question ‘Have you had any signs of pollen
allergy or allergy to furred pets during the last 12 months?’
Another 79 adolescents had atopic eczema without any
other allergic disease manifestation. Atopic eczema was
defined as a pruritic, chronic or chronically relapsing
noninfectious dermatitis with typical features and distribu-
tion, fulfilling three of the main criteria suggested by
Hanifin and Rajka (12). We also identified 332 adolescents
who were free of any allergic symptoms and had not
displayed any positive reaction in the skin prick test during
any of the follow-ups during childhood.
From the three clinical groups, we randomly selected 53
cases with respiratory allergy, but no other allergic disease,
40 cases with atopic eczema, but no other allergic disease,
and 55 nonallergic and nonsensitised controls. Of these
148 adolescents, 128 were previously investigated regard-
ing fatty acid proportions in cord serum obtained at birth
(5). The atopic eczema group was mainly skin prick
negative (36/40), while all the adolescents in the respira-
tory allergy group had to have at least one positive skin
prick test.
Analysis of fatty acids in serum
Venous blood (10 mL) was drawn from the adolescents,
allowed to clot and centrifuged. Serum was separated,
aliquoted and frozen within 3 h. It was stored at 80 °C
until analysed.
Lipids were extracted from serum with chloroform and
methanol (1:2) (13). The phospholipid fraction was sepa-
rated on aminopropyl solid-phase extraction columns (Iso-
lute NH2, 6 mL, 50 mg, IST, Mid Glamorgon, UK) (14), and
the fatty acids were then converted to methyl esters using
acetyl chloride (10%) dissolved in methanol (15). After
methylation, the fatty acids were separated by gas chroma-
tography (Hewlett Packard 5890, Waldbronn, Germany) on
a HP Ultra 1 column (50 m 9 0.32 mm 9 0.52 lm DF,
J&W Scientific, California, USA). Detection was carried out
by flame ionisation, and the Borwin software (Le Fontanil,
France) was used for evaluation. Polyunsaturated fatty acids
that were found in sufficient amount and could clearly be
separatedwere selected for statistical analyses (20:2 n-6, 20:3
n-6, 20:4 n-3, 20:4 n-6, 20:5 n-3, 22:4 n-6, 22:5 n-6, 22:5 n-3
and 22:6 n-3). We also analysed the total proportions of n-3
and n-6 LCPUFAs as well as the total proportion of all
LCPUFAs, by summing the proportions of the nine individ-
ual LCPUFA species.
Assessment of dietary intake of seafood
In relation to blood sampling, the adolescents were asked
to fill out a food frequency questionnaire (FFQ) with the
aid of an accompanying parent. The questionnaire was
based on the validated Northern Sweden FFQ (16) and
contained 52 questions covering intake of selected food
items that could be expected to affect fatty acid pattern in
serum, for example fatty fish, lean fish, shellfish and n-3/n-
6 supplements. Options for intake frequencies included
never, once a month, once a week and daily, as well as a
comment field where respondents could report frequencies
in detail. Frequencies were converted to intake in grams
using the 2001 Swedish National Food Agency’s weight
table.
© 2014 The Authors. Acta Pædiatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Pædiatrica. 2014 103, pp. 968–976 969
Barman et al. Fatty acids and allergy development
Ethic statement
The study was conducted according to the second Decla-
ration of Helsinki (http://www.wma.net/en/30publica-
tions/10policies/b3/index.html) and was approved by the
local ethical committee in Umea, Sweden (Dnr 09-110M).
At 13 years of age, the adolescents were able to provide
their own verbal approval for the skin prick tests and for the
fatty acid analyses in the new serum samples. In addition,
their parents provided a written consent form on behalf of
the children. Participation was voluntary, and the subjects
were free to withdraw, at any time and without any stated
reason, without being disadvantaged in any way.
Statistical analysis
Multivariate analysis
We used partial least squares discriminant analysis (PLS-
DA) (17) to find a model able to separate the three clinical
classes: nonallergic, atopic eczema and respiratory allergy,
based on the proportion of each of nine specified n-3 and n-
6 LCPUFAs, as well the sum of n-3 LCPUFAs, n-6
LCPUFAs, total LCPUFAs, and the ratios of arachidonic
acid (AA) over docosahexaenoic acid (DHA) and total n-6
LCPUFAs over total n-3 LCPUFAs (Fig. 1). If a PLS-DA
model is achieved, the variables that contribute to the
separation of the classes can be identified. This method
permits an evaluation of differences in variable values
without the risk of mass significance and need for normal
distribution of data or strict independence among variables
as in conventional statistics. PLS-DA was performed using
Simca 13.0 (Umetrics, Umea, Sweden).
Univariate analysis
Chi-square test was used to analyse differences in back-
ground variables between the selected individuals and the
groups from which they were selected. Intake of seafood
(not normally distributed) was compared pairwise between
the diagnostic groups using Mann–Whitney U-test. Paired t-
test was used to compare proportions of fatty acids in the
same individuals between cord blood and blood collected at
13 years of age, and data from each diagnostic group were
calculated separately. Pearson’s correlation test was used
for correlations between normally distributed variables,
such as fatty acid proportions in serum, while Spearman’s
rank test was used to correlate intake of seafood (not
normally distributed) with serum fatty acid pattern. All
univariate statistical analyses were performed using IBM
SPSS Statistics version 19 (IBM Corporation, New York,
USA), and p ≤ 0.05 was considered significant.
RESULTS
In this study, allergic 13-year-old subjects were compared to
nonallergic subjects of the same age regarding fatty acid
proportions in serum phospholipids. In all, 148 subjects
were chosen based on their clinical diagnosis at 13 year of
age, that is, respiratory allergy (n = 53), atopic eczema
(n = 40) or no allergy (n = 55). Selected adolescents did not
differ statistically from those in the groups from which they
were selected (Table 1). Atopic eczema was disproportion-
ately more common among female individuals (p = 0.024)
A
B
C
Figure 1 Partial least squares discriminant analysis (PLS-DA), showing the
separation of the three groups, nonallergic, atopic eczema and respiratory
allergy, according to fatty acid profile in serum at 13 years of age. The PLS-DA
score plot (A) shows an overview of the separation between the three clinical
groups. Each symbol represents one individual, and the position of the symbol is
achieved through a combination of this individual’s value of all variables. The
PLS-DA loading plot (B) display to what extent the different variables contribute
to the separation of the three groups; higher the bar, higher the discriminatory
power. The variable of importance (VIP) plot (C) shows to what degree the
different variables contribute to the group separation.
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and respiratory allergy among male individuals (p < 0.001)
(Table 1).
LCPUFA pattern in serum of allergic and nonallergic
adolescents
Serum from 13-year-old individuals with respiratory allergy,
atopic eczema or no allergy was analysed regarding
LCPUFA proportions. We used the multivariate pattern
recognition method PLS-DA to investigate whether the
three diagnostic groups could be separated based on serum
LCPUFA pattern. As shown in Figure 1A, the three groups
were poorly separated from one another, suggesting that the
proportions of different LCPUFAs in serum did not differ
much between the different groups (Fig. 1B). The contri-
bution of each variable to the group separation is shown in
Figure 1C (variable of importance plot). The plot shows
that the AA/DHA ratio and the total n-6/total n-3 ratio
differed most between allergic and nonallergic individuals,
being higher in the allergic groups than in the nonallergic
group (Fig. 1B). Univariate analysis confirmed that the AA/
DHA ratio was significantly elevated in subjects with respi-
ratory allergy (2.6  0.64) and atopic eczema (2.6  0.58)
compared with nonallergic subjects (2.3  0.47) (p = 0.018
and 0.023, respectively). The difference in ratio of total n-6
LCPUFA/total n-3 LCPUFA was not confirmed by univar-
iate analysis (respiratory allergy: 2.3  0.48, atopic eczema:
2.3  0.39, p = 0.068 and 0.185, respectively, compared
with nonallergic subjects, 2.2  0.40).
Changes in serum fatty acids between birth and 13 years
of age in allergic and nonallergic adolescents
Cord blood serum samples had been collected from 128 of
the 148 adolescents at birth and analysed for LCPUFA
pattern (5). Figure 2 shows the changes in proportion of the
major n-3 and n-6 LCPUFAs between birth and 13 years of
age in these individuals. The analyses were carried out
separately for the three diagnostic groups, and the three
single fatty acids found in the highest proportions, that is,
DHA, dihomo-c-linolenic acid (DGLA) and AA, as well as
total n-3 LCPUFA, total n-6 LCPUFA and total LCPUFA,
are shown. The proportion of total n-3 LCPUFA increased
significantly in all three groups (nonallergic, atopic eczema
Table 1 Characteristics of the study population
Nonallergic Atopic eczema* Respiratory allergy†
All, % (n = 332)
Randomly
selected
(n = 55) p-value‡
All, %
(n = 79)
Randomly
selected
(n = 40) p-value‡ All, % (n = 130)
Randomly
selected
(n = 53) p-value‡
Gender (female) 56 (177/330) 65 (36/55) 0.16 70 (55/79) 70 (28/40) 1.0 33 (43/130) 32 (18/53) 0.91
Have older siblings§ 60 (181/302) 69 (38/55) 0.35 58 (46/79) 60 (24/40) 0.59 65 (85/130) 62 (33/53) 0.51
Exclusive
breastfeeding
at 4 months§
71 (211/299) 70 (35/50) 0.82 78 (59/76) 76 (29/38) 0.52 73 (92/126) 69 (35/51) 0.30
Maternal allergic
heredity¶
33 (106/329) 36 (20/55) 0.55 52 (41/79) 45 (18/40) 0.48 55 (72/130) 57 (30/53) 0.88
Asthma 6 (20/329) 5 (3/55) 0.86 23 (18/79) 20 (8/40) 0.73 17 (22/130) 25 (13/53) 0.24
Rhinitis 11 (37/329) 16 (9/55) 0.28 24 (19/79) 20 (8/40) 0.62 33 (43/130) 40 (21/53) 0.40
Eczema 23 (75/329) 22 (12/55) 0.87 38 (30/79) 33 (13/40) 0.56 32 (41/130) 28 (15/53) 0.67
Paternal allergic
heredity¶
32 (105/324) 31 (17/55) 0.83 37 (29/79) 25 (10/40) 0.65 48 (62/129) 50 (26/52) 0.81
Asthma 11 (35/324) 11 (6/55) 0.98 8 (6/79) 8 (3/40) 0.99 16 (20/129) 15 (8/52) 0.98
Rhinitis 15 (47/324) 15 (8/55) 0.99 19 (15/79) 15 (6/40) 0.59 32 (41/129) 36 (19/52) 0.54
Eczema 16 (52/324) 7 (4/55) 0.09 25 (20/79) 23 (9/40) 0.74 19 (25/129) 23 (12/52) 0.58
Cat during first
year in life§
19 (64/331) 24 (13/55) 0.46 23 (19/79) 25 (10/40) 0.91 12 (16/130) 13 (7/53) 0.87
Dog during first
year in life¶
30 (99/331) 20 (11/55) 0.13 29 (23/79) 30 (12/40) 0.92 16 (21/130) 15 (8/53) 0.86
Living in
urban area**
7 (18/242) 3 (1/37) 0.32 7 (4/56) 4 (1/28) 0.52 12 (12/103) 9 (4/43) 0.68
*Defined as a pruritic, chronic or chronically relapsing noninfectious dermatitis with typical features and distribution three of the main criteria suggested by Hanifin
and Rajka (18), diagnosed at 13 years of age.
†Fulfilling ≥1 of the following criteria: wheeze in the past year, asthma inhalation treatment or a positive answer to the question: ‘Have you had any signs of pollen
allergy or allergy to furred pets during the last 12 months?’, diagnosed at 13 years of age.
‡Chi-square test between the whole group and the randomly selected group.
§Answered at 1 year of age.
¶Defined as an affirmative answer to the question ‘Has the child’s mother/father ever had asthma, hay fever or eczema?’, answered at 13 years of age.
**Answered at recruitment in mid-pregnancy.
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Figure 2 Line chart showing the change of fatty acid proportions in serum phospholipids [% of serum phospholipids] in each individual between cord serum drawn at
birth and adolescent serum drawn at 13 years of age for each clinical group. The p-values are from paired t-test. D shows the mean difference between proportion in
cord serum and proportion in adolescent serum. Abbreviations and explanations: LCPUFA, long-chain polyunsaturated fatty acids; total n-3 LCPUFA, sum of 20:4, 20:5,
22:5 and 22:6; total n-6 LCPUFA, sum of 20:2, 20:3, 20:4, 22:4 and 22:5; total LCPUFA, sum of total n-3 and total n-6 LCPUFA.
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and respiratory allergy), but more so in the nonallergic
group. Conversely, total n-6 LCPUFA proportions
decreased significantly in all three groups, but most strongly
in the allergic groups. For DHA, the major n-3 LCPUFA
found in serum phospholipids, the proportions increased
over time from cord serum to adolescent serum in nonal-
lergic subjects, whereas it decreased in the two allergic
groups. The same was true for the total proportion of
LCPUFAs among serum phospholipids, which increased
between birth and 13 years of age in nonallergic individuals,
while it decreased significantly both in the atopic eczema
and respiratory allergy groups (Fig. 2). We had previously
reported higher levels of both n-3 and n-6 LCPUFAs in cord
blood of individuals who later developed allergy (5). As
nonallergic individuals tended to increase their n-3
LCPUFA levels more than the allergic groups and decrease
their n-6 LCPUFA levels less, the differences between the
groups were evened out, which resulted in the lack of
significant differences at the group level at 13 years of age
(Fig. 1).
Correlation between serum fatty acids at birth and at 13
years of age in allergic and nonallergic adolescents
We also investigated whether the individuals who had the
highest proportions of a particular LCPUFA at birth also
had the highest proportions 13 years later and vice versa.
Correlations were analysed separately for the three diag-
nostic groups for the three single fatty acids that are
dominating in proportion in serum (DHA, DGLA and AA)
as well as total n-3 LCPUFA, total n-6 LCPUFA and total
LCPUFA (Table 2). In the nonallergic group, two variables
(DGLA and total LCPUFA) showed a modest (>0.4)
correlation and three variables (DHA, total n-3 LCPUFA
and total n-6 LCPUFA) weak correlation (>0.3) between
the proportions in cord serum and in serum drawn at 13
years of age. By contrast, in the respiratory allergy group,
there were no correlations between the individuals’ mea-
sures of any LCPUFA types between birth and at 13 years of
age. In the atopic eczema group, one variable (total n-3
LCPUFA) showed a weak correlation (>0.3) between the
proportion in cord serum and in serum drawn at 13 years of
age (Table 2).
Correlation between intake of seafood and proportions of
LCPUFAs in serum phospholipids in allergic and
nonallergic adolescents
The proportion of DHA in serum phospholipids was slightly
higher in nonallergic 13-year-old adolescents than in those
with allergies (Fig. 1). LCPUFAs of the n-3 series are
foremost found in seafood, that is, both fatty and lean fish,
as well as other seafood. Intake of seafood at 13 years of age
was assessed by a food frequency questionnaire, and the
intake of seafood (in grams per week) was calculated for the
three groups. As shown in Table 3, there were no significant
differences in intake of lean fish, fatty fish or total seafood
between allergic and nonallergic subjects.
We correlated the proportions of DHA and total n-3
LCPUFAs in serum phospholipids with the reported intake
frequencies of total seafood, in the three diagnostic groups
(Fig. 3). In nonallergic subjects, higher intake of seafood
resulted in increased serum proportions of DHA (r = 0.46,
p < 0.001), as well as total n-3 LCPUFA (r = 0.46,
p < 0.001) among serum phospholipids (Fig. 3, left panel).
In subjects with respiratory allergy, there was a weak, but
still significant, correlation between intake of seafood and
DHA (r = 0.29, p = 0.036) and a weak nonsignificant
positive correlation between intake of seafood and total
n-3 LCPUFA proportions (r = 0.24, p = 0.086) in serum
phospholipids (Fig. 3, middle panel). In subjects with atopic
eczema, however, intake of seafood did not result in any
increase in either serum proportions of DHA (r = 0.16,
p = 0.319) or total n-3 LCPUFAs (r = 0.03, p = 0.845)
(Fig. 3, right panel). We also correlated the serum propor-
tions of DHA and total n-3 LCPUFA to the intake of fatty
fish, rather than the total seafood intake. Among nonaller-
gic individuals, fatty fish intake correlated moderately with
DHA and total n-3 in serum (r = 0.30, p = 0.026 for DHA
and r = 0.30, p = 0.028 for total n-3 LCPUFA). This pattern
was also seen in individuals with respiratory allergy
(r = 0.32, p = 0.022 for DHA and r = 0.33, p = 0.017 for
total n-3 LCPUFA) but not among individuals with atopic
eczema (r = 0.18, p = 0.26 for DHA and r = 0.041, p = 0.80
for total n-3 LCPUFA).
EPA in serum phospholipids correlated with fatty fish
intake and total seafood intake in a similar manner as did
DHA and total n-3 LCPUFAs. For nonallergic individuals,
EPA showed a nonsignificant correlation with fatty fish
intake (r = 0.241, p = 0.076) and a significant correlation
with total seafood intake (r = 0.391, p = 0.003). This was
also seen for subjects with respiratory allergy in whom EPA
was nonsignificantly correlated with fatty fish intake
(r = 0.254, p = 0.070) and significantly correlated with total
seafood intake (r = 0.220, p = 0.118). In subjects with
Table 2 Correlations between proportions of LCPUFAs in serum phospholipids
obtained at birth and at 13 years of age in the same individuals‡
Nonallergic
(n = 48†)
Respiratory allergy
(n = 43†)
Atopic eczema
(n = 37†)
22:6 n-3 (DHA) 0.347* 0.050 0.310
20:3 n-6 (DGLA) 0.441** 0.116 0.105
20:4 n-6 (AA) 0.268 0.040 0.313
Total n-3 LCPUFA 0.352* 0.183 0.391*
Total n-6 LCPUFA 0.345* 0.020 0.170
Total LCPUFA 0.437*** 0.110 0.241
LCPUFA = long-chain polyunsaturated fatty acids. Total n-3 LCPUFA is the
sum of 20:4, 20:5, 22:5 and 22:6. Total n-6 LCPUFA is the sum of 20:2,
20:3, 20:4, 22:4 and 22:5. Total LCPUFA is the sum of total n-3 and total n-6
LCPUFA.
*p ≤ 0.05.
**p ≤ 0.01.
***p ≤ 0.001.
†Number of individuals with fatty acid proportions analysed both at birth and
13 years later.
‡Pearson’s correlation coefficient.
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atopic eczema, EPA correlated neither with fatty fish intake
(r = 0.000, p = 0.998) nor with total seafood intake
(r = 0.056, p = 0.719).
DISCUSSION
We have recently shown that adolescents with atopic
eczema or respiratory allergy at 13 years of age were
characterised by higher proportions of many LCPUFAs in
phospholipids of serum obtained at birth, compared with
individuals who remained nonsensitised and nonallergic
during their first 13 years of life (5). Here, we investigate
whether such differences in LCPUFA pattern could be
detected in serum at 13 years of age. We used a multivariate
approach to achieve this first aim. Partial least square
discriminant analysis (PLS-DA) can be used to separate
predetermined groups of observations (in this case individ-
uals with different diagnoses at 13 years of age: nonallergic,
respiratory allergy or atopic eczema) based on the values of
all measured parameters (here the proportions of LCPUFA
species). It was clear that the three diagnostic groups
(nonallergic, respiratory allergy and atopic eczema) could
not be separated based on their fatty acid pattern in serum
at 13 years of age. A similar result was recently found by
Standl et al. (18), who analysed fatty acids in cord blood
and in blood collected at two, six and 10 years in the
LISAplus birth cohort. At 10 years of age, which is close to
the age of the subjects in this study, no differences were
found between subjects with asthma, hay fever or eczema
and nonallergic controls regarding total n-3 LCPUFA, total
n-6 LCPUFA or n-6/n-3 ratio.
Fatty acids in cord blood are transported from the
maternal circulation across the placenta during pregnancy.
Some fatty acids are transported actively, including several
n-3 PUFAs and n-6 PUFAs, while others diffuse passively,
including saturated fatty acids and monounsaturated fatty
Figure 3 Correlations between intake of total seafood [gram/week] and proportions of DHA and total n-3 LCPUFAs in serum [% of total serum phospholipids] for each
studied group. *p ≤ 0.05, ***p ≤ 0.001.
Table 3 Intake of seafood and fish oil capsules at 13 years of age*
Nonallergic
(n = 53)†
Respiratory
allergy (n = 49)†
Atopic eczema
(n = 39)†
p (respiratory
vs control)‡
p (eczema
vs control)‡
Lean fish 77  57 72  61 85  58 0.63 0.41
Fatty fish 73  58 61  57 86  63 0.32 0.34
Total seafood§ 158  93 142  106 180  102 0.32 0.45
Fish oil capsules 0.49  1.7 0.51  2.2 0.56  2.5 0.83 0.79
*Shown as mean  SD [g/week].
†Number of subjects that have filled in a complete food frequency questionnaire in each group.
‡p-value obtained by nonparametric Mann–Whitney U-test.
§Including fatty and lean fish, as well as shellfish.
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acids (6). Fatty acid composition in cord serum is therefore
a function of the efficiency of the placental fatty acid
transport proteins, the elongation of essential fatty acids to
LCPUFAs by the foetus or by the concentration of fatty
acids in the maternal circulation. In children and adults, the
fatty acid composition of serum phospholipids is mainly
determined by dietary intake of fatty acid rich food. Hence,
the proportions of cord and adolescent blood LCPUFAs are
determined by different factors. The longer n-3 and n-6
LCPUFAs can also be synthesised from the shorter essential
linoleic and a-linolenic acid, but only at low efficiency (19).
The capacity to elongate medium-sized fatty acids to
LCPUFA is determined by genetic factors (20).
It is not very well known how the proportions of
LCPUFAs in serum change from birth to adolescence.
Here, we show that the proportion of n-3 LCPUFAs
increase over time, while the proportion of n-6 LCPUFAs
decrease over time. The increase in n-3 LCPUFAs was more
pronounced among nonallergic individuals than among
allergic individuals. Furthermore, the two allergic groups
showed a significant decrease in total LCPUFA proportions
between birth and 13 years of age, while this was not seen in
the nonallergic group. Infants who later developed allergy
were born with higher proportions of a range of LCPUFAs,
and a higher total proportion of LCPUFA, than individuals
who remained nonallergic (5). The decrease in total
LCPUFA proportions (from birth to adolescence) in the
allergic groups eradicated the differences between allergic
and nonallergic subjects at birth. Hence, at 13 years of age,
allergic and nonallergic individuals did not differ in the
proportion of total LCPUFAs in serum phospholipids.
We analysed the correlation between fatty acid propor-
tions at birth and at 13 years of age in the same
individuals. In the nonallergic group, we found significant
correlations between birth and adolescence, for DHA,
DGLA as well as for total n-3 LCPUFA, total n-6 LCPUFA
and the total LCPUFA proportions, that is, individuals
who had high proportions at birth also tended to have
high proportions at 13 years of age. It should be recog-
nised, however, that a regression coefficient of 0.4 means
that only 16% of the difference in proportions of a certain
LCPUFA at 13 years of age may be predicted from the
proportions at birth. The correlations between birth and
13-year proportions of different LCPUFAs were even
weaker in the atopic eczema group and nonexisting in
the respiratory allergy group.
Several studies have explored the association between
diet and allergy. Fish intake is associated with reduced risk
of asthma in adults (21–23) and children (24), and early
introduction of fish into the diet is associated with reduced
risk of development of eczema (25–27). However, one study
reported higher prevalence of asthma among children who
consumed fish one to two times a week than among
children who consumed fish less often (28). In the present
study, we did not observe any difference in fish intake
between allergic and nonallergic individuals.
Several studies have shown that dietary intake of n-3
LCPUFAs is reflected in serum (29). However, to our
knowledge, no studies have analysed if the intake of seafood
(rich in n-3 LCPUFA) correlate with the proportions of n-3
LCPUFA serum phospholipids in allergic subjects and if it
differs depending on allergic manifestation. Therefore, we
analysed the correlation between intake of seafood and the
proportion of n-3 LCPUFAs in serum in both nonallergic
adolescents and in those with eczema and respiratory
allergy. We found that there was a correlation between
intake of seafood and the proportion of n-3 LCPUFA in
serum phospholipids in nonallergic individuals and in
subjects with respiratory allergy, but not in subjects with
atopic eczema. Thus, nonallergic individuals who con-
sumed high levels of seafood had higher proportions of
EPA, DHA and total n-3 LCPUFA among their serum
phospholipids than those who consumed little seafood. This
was not seen in individuals with atopic eczema, whose
LCPUFA serum proportions did not correlate with fish
intake. We have previously found that women with both
respiratory allergy and atopic eczema have lower propor-
tions of n-3 LCPUFAs in serum and breastmilk, as
compared to nonallergic women or women with isolated
respiratory allergy, despite a greater intake of fish in the first
group (9). Similar result was found by Dunder et al. (30)
who reported that children with atopic dermatitis had lower
levels of EPA and DHA than nonallergic controls, despite a
similar fish intake. Accordingly, in the present study, we
found that allergic individuals had lower DHA levels than
the nonallergic despite similar seafood intake. Moreover,
LCPUFAs was observed to be consumed during allergic
inflammation in an experimental mouse model of respira-
tory allergy (8). These findings support the notion that the
fatty acid metabolism differs in allergic and nonallergic
persons. We propose that bodily consumption of LCPUFAs
during allergic inflammation might explain these findings.
Another possible explanation is that allergic individuals
would be more prone to report their intake, as compared to
nonallergic individuals. People with a chronic disease might
be more conscious than healthy people of diet and other
factors that are seen as affecting health.
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